Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endometrial Cancer Recurrence in Patients Taking Metformin

NCT05192850 is registered in ClinicalTrials.gov with WellSpan Health as lead sponsor.

NCT NCT05192850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05192850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endometrial Cancer Recurrence in Patients Taking Metformin
Lead sponsor
WellSpan Health
Phase
Observational
Overall status
Withdrawn
Start date
December 27, 2021
Completion date
February 27, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent endometrial carcinoma